Entering text into the input field will update the search result below

Denali Therapeutics prices IPO at $18/share

Dec. 07, 2017 7:19 PM ETDenali Therapeutics Inc. (DNLI) StockBy: Jason Aycock, SA News Editor
  • Denali Therapeutics (NASDAQ:DNLI) has priced its initial public offering at $18/share, the midpoint of its expected range.
  • With 13,888,888 shares in the offering, gross proceeds come to $250M. Underwriters have a 30-day option to buy up to 2,083,333 more shares at the IPO price.
  • Shares are expected to begin trading on Nasdaq tomorrow, with the offering closing Dec. 12.
  • Goldman Sachs, Morgan Stanley and J.P. Morgan are joint book-runners.

Recommended For You

More Trending News

About DNLI Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
DNLI--
Denali Therapeutics Inc.